General Information of This Metabolic Reaction (MR) (ID: MR002621)
Formula Reactant Adefovir Dipivoxil(ADV-DP)2 Product Adefovir Diphosphate(ADV-DP)4
Reactant Info Product Info
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR011016 Adefovir Adefovir Dipivoxil Unclear - Unclear adefovir [1]
MR002623 Adefovir Adefovir Dipivoxil(ADV-DP)2 Unclear ICN-2001-3 [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR011017 Adefovir Dipivoxil Adefovir diphosphate Unclear - Unclear adefovir [1]
MR011015 Cyclic prodrug of Adefovir 3 Adefovir Diphosphate Unclear - Unclear adefovir [1]
MR000063 Adefovir monophosphate Adefovir Diphosphate Other reaction - Phosphorylation Adefovir dipivoxil [2]
MR002620 Cyclic prodrug of Adefovir 3 Adefovir Diphosphate(ADV-DP)4 Unclear ICN-2001-3 [1]
References
1 Pradefovir: a prodrug that targets adefovir to the liver for the treatment of hepatitis B J Med Chem. 2008 Feb 14;51(3):666-76. doi: 10.1021/jm7012216.
2 Effective metabolism and long intracellular half life of the anti-hepatitis B agent adefovir in hepatic cells Biochem Pharmacol. 2004 Nov 1;68(9):1825-31. doi: 10.1016/j.bcp.2004.07.010.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.